Cargando…
Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
INTRODUCTION: Lewy body and Alzheimer-type pathologies often co-exist. Several studies suggest a synergistic relationship between amyloid-β (Aβ) and α-synuclein (α-syn) accumulation. We have explored the relationship between Aβ accumulation and the phosphorylation of α-syn at serine-129 (pSer129 α-s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248436/ https://www.ncbi.nlm.nih.gov/pubmed/25452767 http://dx.doi.org/10.1186/s13195-014-0077-y |
_version_ | 1782346802184323072 |
---|---|
author | Swirski, Marta Miners, J Scott de Silva, Rohan Lashley, Tammaryn Ling, Helen Holton, Janice Revesz, Tamas Love, Seth |
author_facet | Swirski, Marta Miners, J Scott de Silva, Rohan Lashley, Tammaryn Ling, Helen Holton, Janice Revesz, Tamas Love, Seth |
author_sort | Swirski, Marta |
collection | PubMed |
description | INTRODUCTION: Lewy body and Alzheimer-type pathologies often co-exist. Several studies suggest a synergistic relationship between amyloid-β (Aβ) and α-synuclein (α-syn) accumulation. We have explored the relationship between Aβ accumulation and the phosphorylation of α-syn at serine-129 (pSer129 α-syn), in post-mortem human brain tissue and in SH-SY5Y neuroblastoma cells transfected to overexpress human α-syn. METHODS: We measured levels of Aβ40, Aβ42, α-syn and pSer129 α-syn by sandwich enzyme-linked immunosorbent assay, in soluble and insoluble fractions of midfrontal, cingulate and parahippocampal cortex and thalamus, from cases of Parkinson’s disease (PD) with (PDD; n = 12) and without dementia (PDND; n = 23), dementia with Lewy bodies (DLB; n = 10) and age-matched controls (n = 17). We also examined the relationship of these measurements to cognitive decline, as measured by time-to-dementia and the mini-mental state examination (MMSE) score in the PD patients, and to Braak tangle stage. RESULTS: In most brain regions, the concentration of insoluble pSer129 α-syn correlated positively, and soluble pSer129 α-syn negatively, with the levels of soluble and insoluble Aβ. Insoluble pSer129 α-syn also correlated positively with Braak stage. In most regions, the levels of insoluble and soluble Aβ and the proportion of insoluble α-syn that was phosphorylated at Ser129 were significantly higher in the PD and DLB groups than the controls, and higher in the PDD and DLB groups than the PDND brains. In PD, the MMSE score correlated negatively with the level of insoluble pSer129 α-syn. Exposure of SH-SY5Y cells to aggregated Aβ42 significantly increased the proportion of α-syn that was phosphorylated at Ser129 (aggregated Aβ40 exposure had a smaller, non-significant effect). CONCLUSIONS: Together, these data show that the concentration of pSer129 α-syn in brain tissue homogenates is directly related to the level of Aβ and Braak tangle stage, and predicts cognitive status in Lewy body diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13195-014-0077-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4248436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42484362014-12-02 Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease Swirski, Marta Miners, J Scott de Silva, Rohan Lashley, Tammaryn Ling, Helen Holton, Janice Revesz, Tamas Love, Seth Alzheimers Res Ther Research INTRODUCTION: Lewy body and Alzheimer-type pathologies often co-exist. Several studies suggest a synergistic relationship between amyloid-β (Aβ) and α-synuclein (α-syn) accumulation. We have explored the relationship between Aβ accumulation and the phosphorylation of α-syn at serine-129 (pSer129 α-syn), in post-mortem human brain tissue and in SH-SY5Y neuroblastoma cells transfected to overexpress human α-syn. METHODS: We measured levels of Aβ40, Aβ42, α-syn and pSer129 α-syn by sandwich enzyme-linked immunosorbent assay, in soluble and insoluble fractions of midfrontal, cingulate and parahippocampal cortex and thalamus, from cases of Parkinson’s disease (PD) with (PDD; n = 12) and without dementia (PDND; n = 23), dementia with Lewy bodies (DLB; n = 10) and age-matched controls (n = 17). We also examined the relationship of these measurements to cognitive decline, as measured by time-to-dementia and the mini-mental state examination (MMSE) score in the PD patients, and to Braak tangle stage. RESULTS: In most brain regions, the concentration of insoluble pSer129 α-syn correlated positively, and soluble pSer129 α-syn negatively, with the levels of soluble and insoluble Aβ. Insoluble pSer129 α-syn also correlated positively with Braak stage. In most regions, the levels of insoluble and soluble Aβ and the proportion of insoluble α-syn that was phosphorylated at Ser129 were significantly higher in the PD and DLB groups than the controls, and higher in the PDD and DLB groups than the PDND brains. In PD, the MMSE score correlated negatively with the level of insoluble pSer129 α-syn. Exposure of SH-SY5Y cells to aggregated Aβ42 significantly increased the proportion of α-syn that was phosphorylated at Ser129 (aggregated Aβ40 exposure had a smaller, non-significant effect). CONCLUSIONS: Together, these data show that the concentration of pSer129 α-syn in brain tissue homogenates is directly related to the level of Aβ and Braak tangle stage, and predicts cognitive status in Lewy body diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13195-014-0077-y) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-01 /pmc/articles/PMC4248436/ /pubmed/25452767 http://dx.doi.org/10.1186/s13195-014-0077-y Text en © Swirski et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Swirski, Marta Miners, J Scott de Silva, Rohan Lashley, Tammaryn Ling, Helen Holton, Janice Revesz, Tamas Love, Seth Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease |
title | Evaluating the relationship between
amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies
and Parkinson’s disease |
title_full | Evaluating the relationship between
amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies
and Parkinson’s disease |
title_fullStr | Evaluating the relationship between
amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies
and Parkinson’s disease |
title_full_unstemmed | Evaluating the relationship between
amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies
and Parkinson’s disease |
title_short | Evaluating the relationship between
amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies
and Parkinson’s disease |
title_sort | evaluating the relationship between
amyloid-β and α-synuclein phosphorylated at ser129 in dementia with lewy bodies
and parkinson’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248436/ https://www.ncbi.nlm.nih.gov/pubmed/25452767 http://dx.doi.org/10.1186/s13195-014-0077-y |
work_keys_str_mv | AT swirskimarta evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT minersjscott evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT desilvarohan evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT lashleytammaryn evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT linghelen evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT holtonjanice evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT revesztamas evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease AT loveseth evaluatingtherelationshipbetweenamyloidbandasynucleinphosphorylatedatser129indementiawithlewybodiesandparkinsonsdisease |